Literature DB >> 21206192

Mild encephalitis/encephalopathy with a reversible splenial lesion: evaluation by diffusion tensor imaging. Two case reports.

Satoru Osuka1, Hironori Imai, Eiichi Ishikawa, Akira Matsushita, Tetsuya Yamamoto, Hiroki Nozue, Tatsuyuki Ohto, Kousaku Saotome, Yoji Komatsu, Akira Matsumura.   

Abstract

Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) is a clinico-radiological syndrome with a very particular clinical course. Three patients with MERS were evaluated by various sequences of magnetic resonance imaging with diffusion tensor imaging. Initial diffusion-weighted imaging showed reduction in the apparent diffusion coefficient values in the lesions, which completely resolved with the elimination of symptoms. However, diffusion anisotropy of the lesions showed no remarkable abnormalities in the early or delayed phases. These results may indicate that white matter architecture is preserved in both early and delayed phases in MERS.

Entities:  

Mesh:

Year:  2010        PMID: 21206192     DOI: 10.2176/nmc.50.1118

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  10 in total

Review 1.  Mild encephalitis/encephalopathy with a reversible splenial lesion: five cases and a literature review.

Authors:  Jing Jing Pan; You-Yan Zhao; Chao Lu; Yu-Hua Hu; Yang Yang
Journal:  Neurol Sci       Date:  2015-07-01       Impact factor: 3.307

2.  Evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) by diffusion-weighted and diffusion tensor imaging.

Authors:  Balasubramanyam Shankar; Ramakrishna Narayanan; Pushkaran Muralitharan; Balamurugan Ulaganathan
Journal:  BMJ Case Rep       Date:  2014-06-04

3.  Sudden worsening after subdural haematoma surgery: will there be a corpus callosum injury?

Authors:  Pier Paolo Panciani; Elena Roca; Giovanni Lodoli; Marco Maria Fontanella
Journal:  BMJ Case Rep       Date:  2014-05-26

4.  Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.

Authors:  Yuanzhao Zhu; Junjun Zheng; Ling Zhang; Zhenguo Zeng; Min Zhu; Xiaobin Li; Xiaoliang Lou; Hui Wan; Daojun Hong
Journal:  BMC Neurol       Date:  2016-04-18       Impact factor: 2.474

Review 5.  Mycoplasma pneumoniae-associated mild encephalitis/encephalopathy with a reversible splenial lesion: report of two pediatric cases and a comprehensive literature review.

Authors:  Norishi Ueda; Satoshi Minami; Manabu Akimoto
Journal:  BMC Infect Dis       Date:  2016-11-11       Impact factor: 3.090

6.  Hemolytic Uremic Syndrome-associated Encephalopathy Successfully Treated with Corticosteroids.

Authors:  Takashi Hosaka; Kiyotaka Nakamagoe; Akira Tamaoka
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

7.  Sequential occurrence of eclampsia-associated posterior reversible encephalopathy syndrome and reversible splenial lesion syndrome (a case report): proposal of a novel pathogenesis for reversible splenial lesion syndrome.

Authors:  Qing Yang; Can-Can Chang; Mengxiao Liu; Yong-Qiang Yu
Journal:  BMC Med Imaging       Date:  2019-04-30       Impact factor: 1.930

8.  Statistical Analysis of the Apparent Diffusion Coefficient in Patients with Clinically Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Indicates That the Pathology Extends Well beyond the Visible Lesions.

Authors:  Yang Qing; Wang Xiong; Huang Da-Xiang; Zhu Juan; Wang Fei; Yu Yong-Qiang
Journal:  Magn Reson Med Sci       Date:  2019-04-05       Impact factor: 2.471

9.  Cerebral Hyperperfusion and Concomitant Reversible Lesion at the Splenium after Direct Revascularization Surgery for Adult Moyamoya Disease: Possible Involvement of MERS and Watershed Shift Phenomenon.

Authors:  Ryosuke Tashiro; Miki Fujimura; Taketo Nishizawa; Atsushi Saito; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-08-06

10.  Reversible splenial lesion syndrome in children: clinical analysis and summary of a case series.

Authors:  Xinying Zhang; Na Chen; Jiamin Guo; Shuwei Li; Jiaming Xu; Weiwei Zhu; Aihua Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.